Deal overview

Deal overview
Target SPARK THERAPEUTICS INC
Bidder ROCHE HOLDING AG
Price £80.00 Full version or £25.00 Light version
Publication Date Feb 25, 2019
Abstract On 25 February 2019, the quoted Swiss pharmaceutical group Roche Holding AG ("Roche") announced a recommended public offer for Spark Therapeutics Inc ("Spark Therapeutics"), a quoted US-based gene therapy group. The offer of US$ 114.50 per share valued 100% of Spark Therapeutics at approximately US$ 4.3 billion on an enterprise value basis. The closing of the transaction was ...
Number of pages (Full version) 8
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.024522s